NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Overactive bladder
Date of first enrollment	14/11/2007
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : P-4 (Propiverine hydrochloride) INN of investigational material : propiverine Therapeutic category code : 259 Other agents for uro-genital and anal organ Dosage and Administration for Investigational material : P-4 200 mg was administered orally once a day. control material(s) Generic name etc : Placebo INN of investigational material : Therapeutic category code : --- Other Dosage and Administration for Investigational material : Placebo was administered orally once a day.

Outcome(s)

Primary Outcome	Efficacy and safety
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	Not applicable
Gender	Both
Include criteria	Patients with overactive bladder symptoms
Exclude criteria